特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 7月2日，在2025全球数字经济大会上，联合国工业发展组织投资和技术促进办公室与东壁科技数据有限公司联合发布 由中国机构自主创建的全球科技文献数据平台dbdata.com。该平台收录了全世界范围内近9000万条高质量科技文献 元数据，并引入AI功能，助力开展高质量科学技术研究，且基础功能将对全球用户免费开放，为科研人员提供高效的 文献检索、引文分析和数据追踪等服务。 "科学技术研究的全过程，包括问题提出、背景调研、实验设计、数据收集与分析、结果验证、成果推广等各个环节都 离不开科技文献数据平台的支撑。但长期以来，全世界科技工作者使用的科技文献数据库产品均由西方少数国家的科技 出版企业垄断，存在陆续对我国关闭的风险。充分发挥市场力量，建设自主可控的科技文献数据平台，补足我国科技基 础设施短板，刻不容缓。"东壁科技数据创始人、深圳大学特聘教授吴登生说。 作为科研人员开展科研活动的重要工具，科技文献数据平台所收录论文的质量，直接影响科研工作的效率。目前，全球 科技界应用最广泛的科技文献数据库是美国科 ...

7月2日，在2025全球数字经济大会上，联合国工业发展组织投资和技术促进办公室与东壁科技数据有限 公司联合发布由中国机构自主创建的全球科技文献数据平台dbdata.com。该平台收录了全世界范围内近 9000万条高质量科技文献元数据，并引入AI功能，助力开展高质量科学技术研究，且基础功能将对全 球用户免费开放，为科研人员提供高效的文献检索、引文分析和数据追踪等服务。 人工智能正加速赋能千行百业，研发人员在开发全球科技文献数据平台时，也率先引入了AI大模型的 功能。据悉，平台先期引入了两个AI功能，分别是"学者成果解读"和"综述自动生成"功能。利用大模型 的能力，平台相当于给每个用户都配备了"AI助手"，用户可以用通俗的语言向这个助手询问每一个学者 的研究方向、研究特色、突出贡献，甚至是不同学者之间的对比。 来源：北京日报客户端 记者：孙奇茹 如遇作品内容、版权等问题，请在相关文章刊发之日起30日内与本网联系。版权侵权联系电话：010-85202353 "科学技术研究的全过程，包括问题提出、背景调研、实验设计、数据收集与分析、结果验证、成果推 广等各个环节都离不开科技文献数据平台的支撑。但长期以来，全世界科技工 ...

Core Insights - Clarivate Plc has announced a multi-year partnership with the Canadian Research Knowledge Network (CRKN) to provide expanded access to the Web of Science for 55 Canadian universities, enhancing research collaborations and accessibility [1][4]. Company Overview - Clarivate is a leading global provider of transformative intelligence, offering enriched data, insights, analytics, workflow solutions, and expert services across various sectors including Academia & Government, Intellectual Property, and Life Sciences & Healthcare [5]. Industry Impact - The partnership aims to support Canadian researchers by providing access to the Web of Science API, which includes rich metadata to aid research projects, as well as access to the Derwent Innovations Index and the Policy Citation Index to understand the societal impact of research outputs [3][4]. - Canada is recognized for its collaborative position in global academic research, with contributions in innovation and patents exceeding the international average [4].

Core Insights - Clarivate Plc has renewed its partnership with CAPES, significantly expanding access to academic and life sciences data across over 400 Brazilian institutions, increasing institutional coverage by 57% compared to the previous contract [1][2][6] - The partnership aims to democratize access to critical scientific information, enabling researchers and practitioners to conduct innovative research and improve patient care [3][4][6] - The agreement enhances access to various research tools, including Web of Science, Journal Citation Reports, and Cortellis Drug Discovery Intelligence, supporting evidence-based discovery and decision-making [2][5][6] Company and Industry Impact - The collaboration with CAPES reflects a commitment to advancing scientific excellence and reducing regional disparities in Brazil's research landscape [4][6] - The expanded access to trusted research tools is expected to strengthen postgraduate programs and elevate the global visibility of Brazilian research [6][7] - Brazil's research output shows a strong focus on Sustainable Development Goals, particularly in Life Sciences and Medicine, with a notable emphasis on international collaboration [10]

Financial Data and Key Metrics Changes - Q1 revenue was $594 million, with a net loss of $104 million attributed to higher restructuring expenses related to the value creation plan [22][23] - Adjusted diluted EPS was $0.14, flat compared to the same period last year [23] - Adjusted EBITDA margin increased by more than one percentage point due to improved cost management [24] Business Line Data and Key Metrics Changes - Organic annual contract value (ACV) grew sequentially, with total organic revenue increasing for the first time in over a year, and recurring organic revenue grew nearly 1% [6][8] - In the IP Patent Annuity business, organic recurring revenue grew 5% due to higher volumes [12] - Subscription renewal rates in Life Science and Health improved to 90%, an increase of three percentage points over the prior year [13] Market Data and Key Metrics Changes - The mix of recurring revenue to total revenue is now 83%, an improvement of 200 basis points compared to the prior year [6] - The company noted that less than 3% of total revenue comes directly from the U.S. Federal government, indicating limited exposure to government funding cuts [10] Company Strategy and Development Direction - The company is focused on optimizing revenue, improving sales execution, and accelerating innovation through a subscription-centric model [5][8] - The value creation plan is on track, with a focus on business model optimization, sales execution, and accelerated product innovation [15][18] - The company is evaluating strategic alternatives to unlock value and maximize shareholder returns [19] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the future of research in academia despite potential government funding cuts, indicating minimal impact on business so far [39][40] - The company remains cautious about the macroeconomic environment but believes its products' recurring nature positions it well during uncertain times [34] Other Important Information - Free cash flow was strong at $110 million, with nearly half used for share repurchases [26][28] - The company expects annual contract value to accelerate by approximately 60 basis points to 1.5% at the midpoint of the range [29] Q&A Session Summary Question: Concerns about government funding exposure - Management indicated minimal impact from government actions and noted strong renewal rates in the A and G segment [39][42] Question: Inquiry about private equity interest in the IP segment - Management stated they are evaluating strategic options but had no specific comments on the private equity interest [47] Question: Drivers behind higher renewal volumes in IP - The primary driver for the increase in organic recurring revenues was a return to healthy growth in patent and trademark renewals [50][51] Question: Impact of funding cuts on large universities - Management confirmed that less than half of the A and G segment business is in the U.S., with a significant portion already renewed this year [55] Question: Expectations for transactional revenue growth - Management remains conservative about transactional revenue growth, focusing on improving recurring revenues [58] Question: Changes to the sales incentive model - Management highlighted upgrades in sales leadership and changes to the incentive model to reward subscription revenue growth [66] Question: Cyclical nature of patent renewals - Management acknowledged that while patent renewals can be cyclical, they expect the long-term trend to remain positive [70]

Financial Data and Key Metrics Changes - Q1 revenue was $594 million, with a net loss of $104 million attributed to higher restructuring expenses related to the value creation plan [23][24] - Adjusted diluted EPS was $0.14, flat compared to the same period last year [24] - Adjusted EBITDA margin increased by more than one percentage point due to internal cost efficiencies, with free cash flow of $110 million [9][28] Business Line Data and Key Metrics Changes - Organic annual contract value (ACV) grew sequentially, driven by improved subscription renewals and new business wins [7][10] - Organic recurring revenue grew nearly 1%, with renewal rates across the subscription base improving by one percentage point [8][9] - In the IP Patent Annuity business, organic recurring revenue grew 5% due to higher volumes, with a double-digit increase in search volume for the Derwent innovation platform [13][19] Market Data and Key Metrics Changes - The mix of recurring revenue to total revenue is now 83%, an improvement of 200 basis points compared to last year [8][18] - Subscription renewal rates in the Life Science and Health segment improved to 90%, an increase of three percentage points over the prior year [14] Company Strategy and Development Direction - The company is focused on optimizing revenue, improving sales execution, and accelerating innovation through a subscription-centric model [6][10] - The value creation plan is on track despite a volatile macro environment, with a focus on business model optimization and increasing the subscription revenue mix [10][17] - The company is evaluating strategic alternatives to unlock value and maximize shareholder returns [20] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the future of research in academia despite potential government funding cuts, indicating minimal impact on business so far [11][40] - The company remains cautious against a challenging macroeconomic environment but believes its products' recurring nature positions it well [35] Other Important Information - The company has engaged with advisors to analyze options for maximizing shareholder value and will provide updates when appropriate [20] - The company launched new subscription platforms and AI-powered features, enhancing competitive advantage and customer engagement [19][20] Q&A Session Summary Question: Concerns about government funding exposure - Management indicated minimal impact from government actions in Q1 and noted that half of government contracts have already been renewed [40][41] Question: Inquiry about private equity interest in the IP segment - Management stated they are evaluating strategic options but had no specific comments on the private equity interest [48][49] Question: Drivers behind higher renewal volumes in IP - The primary driver for the increase in organic recurring revenues was a return to healthy growth in patent and trademark renewals [52][55] Question: Impact of U.S. government funding on revenue - Less than half of the A and G segment business is in the U.S., with a meaningful portion already renewed this year, indicating confidence in guidance range [59][60] Question: Expectations for transactional revenue growth - Management expects transactional revenue to remain soft in the current macro environment, focusing on improving recurring revenues [62][63] Question: Changes to the sales incentive model - Management highlighted upgrades in sales leadership and changes to the customer success organization, which have contributed to improved renewal rates [67][68] Question: Cyclical nature of patent renewals - Management acknowledged that while patent renewals can fluctuate, the long-term trend is expected to head back in a healthy direction [72][73]